330 likes | 872 Views
Diabetes mellitus complications & morphology. Complications of diabetes. In type 1 &2 diabetes Variable onset, severity ,organs of involvement Macrovascular disease: Accelerated atherosclerosis-MI,CVA,gangrene of legs
E N D
Complications of diabetes • In type 1 &2 diabetes • Variable onset, severity ,organs of involvement • Macrovascular disease: Accelerated atherosclerosis-MI,CVA,gangrene of legs • Microvascular disease (microangiopathy)-retinopathy, nephropathy, neuropathy • Good control of blood glucose minimizes microangiopathy
Pathogenesis • Metabolic derangements, hyperglycemia • Disease modifying elements ? Genetic • 3 probable pathways • Non enzymatic glycosylation:Formation of advanced glycosylation end products (AGE) • Activation of protein kinase C (PKC ) • Intracellular hyperglycemia with disturbances in polyol pathways
Advanced Glycosylation End products(AGE ) • Non enzymatic reaction between *intracellular glucose-derived precusors & *Amino group of intracellular & extracellular proteins Have chemical & biological detrimental effects on extracellular matrix components & target cells of diabetic complications eg endothelial cells
AGE effect on extracellular matrix components • On collagen & laminin • Cross linkage of polylpeptides –abn matrix-matrix or matrix cell linkages • Resistant to proteolytic digestion • Trap non-glycated plasma or interstitial proteins
AGE Effects on Circulating plasma proteins • Generation of cytokines growth factors & pro inflammatory molecules eg insulin like growth factor,TGF β, PDGF,VEGF. • ↑ endothelial permeability • ↑ procoagulant activity • ↑proliferation & synthesis of ECM by fibroblasts & smooth muscle cells
Activation of protein kinase C • Intracellular hyperglycemia causes de-novo synthesis of DAG from glycolytic intermediates & then activation of PKC (Normally by Ca) • Production of VEGF—endothelial &smooth muscle proliferation • ↑ activity of endothelin 1 (vasoconstrictor) • ↓ activity of endothelial NO synthase (vasodilator )-- ↑ microvascular contractility
Intracellular hyperglycemia disturbances in polyol pathways • Hyperglycemia-------------sorbitol--fructose • Aldose reductase-cofactor NADPH • NADPH also needed as cofactor by glutathione reductase to produce reduced glutathione (GSH)-antioxidant • ↑ susceptibility to oxidative stress • Sorbitol may be directly toxic to cells Excessive reactive oxygen species
Complications of DM • Acute metabolic complications DKA, hyperosmolar non ketotic coma,hypoglycemia • Late systemic complications; Macrovascular ,microangoipathy
Macrovascular disease • Accelerated atherosclerosis of aorta & large and medium sized arteries • Myocardial infarction (women & men) • Gangrene of lower limbs • Hyaline arteriosclerosis associated with hypertension
Diabetic microangiopathy • Diffuse thickening of basement membranes (but it is leaky) • Concentric layers of type IV collagen
Diabetic nephropathy • Clinical syndromes • Asymptomatic proteinuria • Nephrotic syndrome • Progressive renal failure • Hypertension • End stage renal failure
Diabetic nephropathy (cont.) • Diabetic glomerulosclerosis:Diffuse glomerulosclerosis:inv all parts of glomerulus • Thickening of GBM &diffuse increase in mesangial matrix and mesangial cells • Capsular drop, • Fibrin cap • Nodular glomerulosclerosis (Kimmelstiel –Wilson lesion)-PAS +,nodule, contain mesangial cells, pathognomonic of DM
Diabetic nephropathy (cont) • Renal vessel atherosclerosis, • Hyaline arteriolosclerosis (afferent & efferent) • Chr Pyelonephritis,necrotizing papillitis • Tubular lesions Armanii Ebstein lesions
Ocular: retinopathy (background non proliferative ,proliferative ),cataract glaucoma • Neuropathy:sensorimotor / autonomic
Pregnancy • Infants of diabetic mothers • Large for date • Hyperplasia of β cells of islet of Langerhan ---hypoglycemia • 5-10% risk of developmental abn of heart; neural tube defects.